Authors: TOMIAK E PICCART M MIGNOLET F SAHMOUD T PARIDAENS R NOOY M BEEX L FENTIMAN IS MULLER A VANDERSCHUEREN E RUBENS RD

Citation: E. Tomiak et al., CHARACTERIZATION OF COMPLETE RESPONDERS TO COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A RETROSPECTIVE EORTC BREAST GROUP-STUDY, European journal of cancer, 32A(11), 1996, pp. 1876-1887

Authors: WYMENGA ANM VANDERGRAAF WTA WILS JA VANHEUKELOM LS VANDERLINDEN GHM DULLEMONDWESTLAND AC NOOY M VANDERHEUL C DEBRUIJN KM DEVRIES EGE

Citation: Anm. Wymenga et al., A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY COMPARING DAILY 2-MG AND 5-MG OF TROPISETRON FOR THE CONTROL OF NAUSEA AND VOMITING INDUCED BY LOW-DOSE CISPLATIN-CONTAINING OR NON-CISPLATIN-CONTAINING CHEMOTHERAPY, Annals of oncology, 7(5), 1996, pp. 505-510

Authors: PUJADELAURAINE E GUASTALLA JP COLOMBO N DEVILLIER P FRANCOIS E FUMOLEAU P MONNIER A NOOY M MIGNOT L BUGAT R MARQUES C MOUSSEAU M NETTER G MALOISEL F LARBAOUI S BRANDELY M

Citation: E. Pujadelauraine et al., INTRAPERITONEAL RECOMBINANT INTERFERON-GAMMA IN OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY, Journal of clinical oncology, 14(2), 1996, pp. 343-350

Authors: VEENHOF CHN VANDERBURG MEL NOOY M AALDERS JG PECORELLI S OLIVEIRA CF ROTMENSZ N VERMORKEN JB

Citation: Chn. Veenhof et al., PHASE-II STUDY OF HIGH-DOSE MEGESTROL-ACETATE IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA, European journal of cancer, 30A(5), 1994, pp. 697-698

Authors: ORNADEL D SOUHAMI RL WHELAN J NOOY M DEELVIRA CR PRINGLE J LEWIS I STEWARD WP GEORGE R BRIDGEWATER J WIERZBICKI R CRAFT AW

Citation: D. Ornadel et al., DOXORUBICIN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA - PHASE-II TRIAL OF THE EUROPEAN-OSTEOSARCOMA-INTERGROUP, Journal of clinical oncology, 12(9), 1994, pp. 1842-1848